Sarepta Therapeutics, Inc. (SRPT) CEO Doug Ingram on Q1 2022 Results - Earnings Call Transcript

Sarepta Therapeutics, Inc. (NASDAQ:NASDAQ:SRPT) Q1 2022 Earnings Conference Call May 4, 2022 16:30 ET Company Participants Mary Jenkins - Senior Manager of Investor Relations Dallan Murray...

Related Keywords

Massachusetts ,United States ,Japan ,Ohio ,Canada ,Bedford ,Kristen Kluska ,Hartaj Singh ,Yun Zhong ,Brian Skorney ,Mary Jenkins ,Timothy Lugo ,Louise Rodino Klapac ,Judah Frommer ,Colin Bristow ,Brian Abrahams ,Ian Estepan ,Doug Ingram ,William Blair ,Joseph Schwartz ,Gil Blum ,Morgan Stanley ,Company Participants ,Credit Suisse ,Nasdaq ,Pfizer ,Needham Company ,Exchange Commission ,Cantor Fitzgerald ,Muscular Dystrophy Association Annual Clinical ,Sarepta Therapeutics Inc ,Oppenheimer Company ,Barclays ,Sarepta Therapeutics ,Conference Call May ,Vice President ,Chief Customer ,Chief Executive ,Chief Financial ,Chief Scientific Officer ,Sarepta Therapeutics First Quarter ,Senior Manager ,Dallan Murray ,Chief Customer Officer ,Momentum Part ,Eastern Ohio ,Dystrophy Association Annual Clinical ,